Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in miceHua Li(First Bethune Hospital of Jilin University), Yongli Yu(Jilin University)OncotargetJuly 19, 201610.18632/oncotarget.10693Cited by 1SaveCiteExport RISWatch citationsRelated PapersMultiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy|Cell|2020|187Massively recruited sTLR9+ neutrophils in rapidly formed nodules at the site of tumor cell inoculation and their contribution to a pro-tumor microenvironment|Cancer Immunology Immunotherapy|2023|7